Analyte Health

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Analyte Health - overview

Established

2010

Location

Houston, TX, US

Primary Industry

Healthcare IT

About

Based in the US, Analyte Health provides accessible online healthcare services through a user-friendly platform, ensuring efficient and private consultations with healthcare professionals. Founded in 2010 in Houston, US, Analyte Health operates online to enhance patient access to healthcare services. The company has engaged in five funding deals, with the latest round raising USD 6. 50 mn.


In August 2025, Analyte Health was acquired by Brightstar Capital Partners, previously backed by several venture firms including Apex Venture Partners. The founder, Fiyyaz Pirani, is instrumental in steering the company's direction. Analyte Health specializes in delivering accessible and affordable online healthcare services that integrate technology with patient-centric care. Their core offerings include a user-friendly online platform for fast and private consultations with trained health counselors and physicians.


Catering to diverse clientele, their 24/7 services address healthcare needs in urban and suburban areas, facilitating timely medical advice and treatment outside traditional settings. Analyte Health's revenue model is based on direct-to-consumer transactions, allowing patients to access various health services promptly. The structure includes service fees for consultations and potential subscription plans for ongoing care. It offers tiered pricing options based on service complexity, ensuring affordable access to care while positioning itself to meet the growing demand for digital health services.


In August 2025, Analyte Health was acquired by Brightstar Capital Partners, with the acquisition aimed at driving long-term growth. The company plans to develop and launch new products while expanding into additional geographic markets, although specific details on the products or target markets have not been disclosed. The funding from the acquisition will support these initiatives, bolstering the company's strategic growth.


Current Investors

Brightstar Capital Partners, Apex Venture Partners, Draper Fisher Jurvetson

Primary Industry

Healthcare IT

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Medical Software

Website

www.analytehealth.com

Verticals

HealthTech

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.